None listed
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients with Implant prosthesis in the mouth for 4year -5 years 2. Systemically healthy 3. No recent consumption of anti-microbial/ anti-inflammatory medication/ topical application of the same upto 4 weeks prior. 4. Patients who provide signed and dated copy of the informed consent form.
Exclusion criteria
Exclusion criteria: 1. Patients with uncontrolled systemic disease 2. Patients with a previous history or existing periodontal disease 3. Pregnant patients or patients on contraception pills or medication which can modify inflammation 4. Use of any systemic medication which would have an effect on gingival conditions within the past 4 weeks .
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To determine the prevalence of peri-implant mucosal inflammation in a 4- 5 year follow up periodTimepoint: To determine the prevalence of peri-implant mucosal inflammation in a 4- 5 year follow up period | — |
Secondary
| Measure | Time frame |
|---|---|
| To identify the site prevalence of Peri-implant inflammation To identify the degree of peri-implant inflammation Timepoint: 4-5 year follow up;To associate presence of inflammation with patient related factors- age of the patient, smoking, oral hygiene regimen of the patient. To associate presence of inflammation with local site related factors- width of attached mucosa, dental plaque at the site To associate presence of inflammation with the implant and prosthetic factors- type of implant, abutment, single or multiple unit prosthesis. Timepoint: 4-5 year follow up | — |
Countries
India
Contacts
no affiliation with any organisation.